UroGen Pharma Ltd.

URGN

Log in to follow and get free email alerts when insiders file.

Sector

Pharmaceutical Preparations

Industry

Drugs

Website

Recent Filings - SEC Insider Transactions (Form 3,4,5)

Date
  • today
  • yesterday
  • week
Price per share
Shares

Transaction Codes

File Date
 
Date
 
Company
 
Filer
 
Security
 
Shares
 
Price
 
$ Total
 
% Change
 
10%
 
Dir.
 
Off.
 
Code
 
View
 
SEC
 
SIC
 
SIC Group
 
SIC Division
 

      Rows per page:

      100

      0-0 of 0

    Buy / Sell (dollars)

    1 Month

    0%0%

    $0.00

    avg. $0.00

    $0.00

    avg. $0.00

    Buy/Sell Ratio

    0


    Transactions

    0

    Filers

    0

    3 Month

    95%5%

    $97,381.00

    avg. $97,381.00

    $5,168.42

    avg. $1,722.81

    Buy/Sell Ratio

    18.842


    Transactions

    15

    Filers

    4

    12 Month

    52%48%

    $176,246.00

    avg. $176,246.00

    $162,997.99

    avg. $13,583.17

    Buy/Sell Ratio

    1.081


    Transactions

    40

    Filers

    31

    24 Month

    67%33%

    $674,648.20

    avg. $674,648.20

    $332,575.11

    avg. $13,857.30

    Buy/Sell Ratio

    2.029


    Transactions

    78

    Filers

    67

    Filers

    CIK
    Name
    Title
    Last Transaction
    First Transaction
    Director
    Officer
    10% Own.
    Other
    1763581Schoenberg MarkChief Medical Officer2021-08-032019-09-06
    1764157Barrett Elizabeth A.Chief Executive Officer2021-07-122019-11-18
    1296549Belldegrun Arie2021-06-092020-02-13
    1206977FALBERG KATHRYN E2021-06-092020-06-10
    1339358Cohen Fred E2021-06-092020-06-10
    1222082BUTITTA CYNTHIA M2021-06-092020-06-10
    1617239Tomasello Shawn2021-06-092020-06-10
    1609805Nussbaum Ran2021-06-092020-06-10
    1763999Holden Stuart2021-06-092020-06-10
    1821479Smith Jason DrewGeneral Counsel2021-06-082020-09-10
    1363812Henderson MollyChief Financial Officer2021-06-082020-10-05
    1585839PFREUNDSCHUH PETER P.Chief Financial Officer2020-10-162019-11-22
    1764139Mullennix StephenChief Operating Officer2020-04-282019-11-18